On Apr. 9, 2020, Washington University School of Medicine in St. Louis launched a clinical trial for patients hospitalized with COVID-19 at Barnes-Jewish Hospital. The tria investigated the effectiveness of different combinations of the antimalarial drugs chloroquine and hydroxychloroquine and the antibiotic azithromycin in treating ill patients infected with the novel coronavirus.